Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future. [electronic resource]
Producer: 20101105Description: 451-64 p. digitalISSN:- 1365-2362
- Annexin A2 -- antagonists & inhibitors
- Anti-Inflammatory Agents -- therapeutic use
- Antibodies, Antiphospholipid -- immunology
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antiphospholipid Syndrome -- etiology
- Complement Activation
- Humans
- Hydroxychloroquine -- therapeutic use
- Immunologic Factors -- therapeutic use
- Monocytes
- NF-kappa B -- physiology
- Platelet Activation
- Rituximab
- Thromboplastin -- antagonists & inhibitors
- p38 Mitogen-Activated Protein Kinases -- physiology
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.